The Shifting Landscape for Specialty Pharmacy Patients

David Lassen, chief clinical officer at Prime Therapeutics, discusses changes in store for the field of specialty pharmacy in the coming years.

Related Content:

Specialty Pharmacy

Study: HPV Vaccine, Surgery May Prevent Return of Cervical Lesions

FDA Approves First Therapy for New HER2-low Breast Cancer Subtype

Patient-Reported Outcome Measures Useful in Clinical Treatment of Pediatric Patients with Cancer